Naik S, Vasileiou S, Tzannou I, Kuvalekar M, et al. Donor-Derived Multiple Leukemia Antigen Specific T-cell Therapy to Prevent Relapse Post-Transplant in Patients with ALL. Blood 2022 Feb 8. pii: 483888. doi: 10.1182/blood.2021014648.
PMID: 35134127